/01/Trillion imagination The term “synthetic biology” first appeared in the 1970s, until it was redefined by Stanford professor Eric Kool in 2000 by introducing engineering concepts based on genomics and systems biology, marking the emergence of this discipline. Simply put, synthetic biology is the use of engineered organisms such as bacteria to produce various…
OpenAI, a well-known developer of ChatGPT, a generative pre training language model, suddenly resigned from Ultraman’s position as CEO on the 17th. Insiders revealed that this is related to AI security claims, development speed, and the commercialization of OpenAI. In fact, as early as April this year, a group of AI industry leaders and experts…
Biomanufacturing technology based on synthetic biology can create novel creations in a flexible and diverse manner that have not been before. However, due to the complexity of biological systems, researchers have to rely on repeated experiments to cultivate and screen engineering microorganisms with superior performance. To reduce the number of experiments and improve the efficiency…
On November 8, 2023 Eastern Time, synthetic biology company Ginkgo Bioworks (NYSE: DNA, hereinafter referred to as Ginkgo) released its financial performance report for the third quarter of 2023. (Source: Company website) According to the company’s official website, Ginkgo’s total revenue in the third quarter of 2023 was $55 million, down from $66 million…
On November 8, 2023, after 15 years, the Synthetic Yeast Genome Project 2.0 (Sc2.0) research team announced a significant milestone: all 16 chromosomes of synthesized yeast, including a newly synthesized tRNA chromosome, have been synthesized, creating a yeast strain containing over 50% synthetic DNA. The relevant achievements have been published in Cell, Molecular Cell, and…
On November 16th local time in the United States, Vertex Pharmaceuticals (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) announced that the UK Medicines and Healthcare Products Regulatory Authority (MHRA) has awarded their jointly developed CRISPR gene editing therapy CASGEVY ™ Conditional marketing license for exaagloggene autotemcel for the treatment of sickle cell anemia (SCD) and…
The accumulation of antibiotics in agricultural soils poses a potential threat to soil ecosystems and crop growth, ultimately posing a threat to human health. Tetracycline antibiotics (TCs), such as tetracycline (CTC), oxytetracycline (OTC), and tetracycline (TTC), are widely present in soil as antibacterial agents. Generally speaking, tetracycline is difficult to completely metabolize in the body,…
Sulfur-containing natural products (sulfur-containing NPs) cover almost every type of NP discovered so far. The source of sulfur in peptide NPs is usually composed of cysteine and methionine. Methionine can be directly incorporated into peptide NPs without any modification, such as precarriebowamide (1). The cysteine residues in peptide NPs are typically embedded in intramolecular disulfides,…
According to incomplete statistics, there are no less than 150 global cell culture meat companies, most of which choose varieties with high consumption such as chicken and beef. However, there is also a problem. Currently, the cost and selling price of cell culture meat are much higher than the cost of breeding meat, which makes…
RNA interference (RNAi) based biopesticides are considered a disruptive technology in the field of plant protection in the future, which will greatly change human thinking and strategies for controlling harmful organisms such as agricultural diseases, insects, and grasses. Although it has not yet been widely used, the cost of RNA production is high, and the…